Literature DB >> 32619584

FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.

Chang'an Zhao1, Liping Mo2, Chao Li3, Shuiping Han2, Wenbo Zhao2, Lifeng Liu4.   

Abstract

Forkhead box N3 (FOXN3) is a subtype of FOX family that has been demonstrated to be implicated in several cancers. However, the role of FOXN3 in papillary thyroid carcinoma (PTC) and its mechanisms have not yet been investigated. Our results showed that FOXN3 was markedly down regulated in PTC tissues and cell lines. Overexpression of FOXN3 suppressed the proliferation, colony formation, migration, and invasion in PTC cells. Overexpression of FOXN3 also prevented EMT process in PTC cells, as shown by the increased E-cadherin expression level and decreased expression levels of N-cadherin and vimentin. In addition, overexpression of FOXN3 inhibited tumor growth of PTC in vivo. Furthermore, overexpression of FOXN3 caused significant decreases in expression levels of β-catenin, c-Myc, and cyclin D1. Additionally, activation of Wnt/β-catenin pathway reversed the effects of FOXN3 on PTC cells. In conclusion, these findings indicated that FOXN3 exerted a tumor suppressive activity in PTC, which was mediated by Wnt/β-catenin pathway.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FOXN3; Migration; Papillary thyroid carcinoma (PTC); Wnt/β-catenin pathway

Mesh:

Substances:

Year:  2020        PMID: 32619584     DOI: 10.1016/j.mce.2020.110925

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

1.  MAGI2-AS3 restrains proliferation, glycolysis, and triggers apoptosis in acute lymphoblastic leukemia via regulating miR-452-5p/FOXN3 pathway.

Authors:  Xiao-Guang Chen; Bing-Hua Dou; Jin-Dou An; Song Feng; Na Liu; Guang-Yao Sheng
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

2.  Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival.

Authors:  Deep Hathi; Chantiya Chanswangphuwana; Nicholas Cho; Francesca Fontana; Dolonchampa Maji; Julie Ritchey; Julie O'Neal; Anchal Ghai; Kathleen Duncan; Walter J Akers; Mark Fiala; Ravi Vij; John F DiPersio; Michael Rettig; Monica Shokeen
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.996

Review 3.  E-cadherin on epithelial-mesenchymal transition in thyroid cancer.

Authors:  Xiaoyu Zhu; Xiaoping Wang; Yifei Gong; Junlin Deng
Journal:  Cancer Cell Int       Date:  2021-12-20       Impact factor: 5.722

4.  FOXN3 inhibits cell proliferation and invasion via modulating the AKT/MDM2/p53 axis in human glioma.

Authors:  Chaojia Wang; Hanjun Tu; Ling Yang; Chunming Ma; Juntao Hu; Jie Luo; Hui Wang
Journal:  Aging (Albany NY)       Date:  2021-09-12       Impact factor: 5.682

Review 5.  Novel Inhibitor-Based Therapies for Thyroid Cancer-An Update.

Authors:  Maciej Ratajczak; Damian Gaweł; Marlena Godlewska
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.